How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Text Messaging as a Screening Tool for Depression and Related Conditions in Underserved, Predominantly Minority Safety Net Primary Care Patients: Validity Study. Full Text available with Trip Pro

Text Messaging as a Screening Tool for Depression and Related Conditions in Underserved, Predominantly Minority Safety Net Primary Care Patients: Validity Study. SMS text messaging is an inexpensive, private, and scalable technology-mediated assessment mode that can alleviate many barriers faced by the safety net population to receive depression screening. Some existing studies suggest that technology-mediated assessment encourages self-disclosure of sensitive health information (...) such as depressive symptoms while other studies show the opposite effect.This study aimed to evaluate the validity of using SMS text messaging to screen depression and related conditions, including anxiety and functional disability, in a low-income, culturally diverse safety net primary care population.This study used a randomized design with 4 study groups that permuted the order of SMS text messaging and the gold standard interview (INTW) assessment. The participants for this study were recruited from

2020 Journal of medical Internet research

2. A Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression (MDHAQ-Dep) in Routine Rheumatology Care. (Abstract)

A Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression (MDHAQ-Dep) in Routine Rheumatology Care. To analyze the use of a multidimensional health assessment questionnaire (MDHAQ) to screen for depression, compared to two reference standards, patient health questionnaire (PHQ-9) and hospital anxiety and depression scale (HADS-D).Patients from Barcelona with a primary diagnosis of rheumatoid arthritis (RA) or spondyloarthritis (SpA) completed MDHAQ, PHQ-9 (...) (depression=≥10), and HADS-D (depression=≥8). The MDHAQ includes two depression items, one in the patient-friendly HAQ 4-point format scored 0-3.3 ("score"), and a "Yes/No" item on a 60-symptom checklist. Percent agreement and kappa statistics quantified agreement between 6 screening criteria: "Yes" on the 60-symptom checklist, score ≥1.1, score ≥2.2, EITHER "Yes" on the 60-symptom checklist OR score ≥2.2, PHQ-9≥10, and HADS-D≥8.Depression screening was positive by 6 criteria in 19.6%-32.4% of 102

2020 Arthritis care & research

3. The development of the visual screening tool for anxiety disorders and depression: Addressing barriers to screening for depression and anxiety disorders in hypertension and/or diabetes Full Text available with Trip Pro

The development of the visual screening tool for anxiety disorders and depression: Addressing barriers to screening for depression and anxiety disorders in hypertension and/or diabetes  There is a lack of screening tools for common mental disorders that can be applied across cultures, languages and levels of education in people with diabetes and hypertension. Aim: To develop a visual screening tool for depression and anxiety disorders that is applicable across cultures and levels of education (...) as associated with depression and anxiety disorders, with no differences between levels of education and cultural groups. Conclusion: Ten drawings were appropriate for inclusion in the visual screening tool for anxiety disorders and depression (VISTAD). The VISTAD will be validated against the mini international neuropsychiatric interview (MINI) in a primary care population with hypertension and/or diabetes.

2018 African journal of primary health care & family medicine

4. Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version. Full Text available with Trip Pro

Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version. Semantic, technical, content, criterion and conceptual equivalence must be examined in order to validate a psychological rating scale in a new cultural setting. Few validation studies have been conducted in sub-Saharan Africa for scales seeking to detect depression in pregnant women. The aim of this study is to validate the 9-item Patient Health Questionnaire (PHQ-9 (...) ) as a screening instrument for depression among Afaan Oromo speaking pregnant Ethiopian women.A random sample of 246 pregnant women were recruited in Seka Chekorsa District, Ethiopia during their first, second or third trimester. One week later, 29 participants were selected to answer the questionnaire for a second time to evaluate test retest reliability. The Mini International Neuropsychiatric Interview (MINI-Plus) scale was used as a gold standard to evaluate validity. PHQ-9 was compared with MINI-Plus

2018 PLoS ONE

5. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women. Full Text available with Trip Pro

Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women. Antenatal depression and anxiety disorders are highly prevalent in low and middle-income countries. Screening of pregnant women in primary care antenatal settings provides an opportunity for entry to care, but data are needed on the performance of different screening tools. We compared five widely-used questionnaires in a sample of pregnant women in urban South (...) Africa.Pregnant women attending a primary care antenatal clinic were administered five tools by trained research assistants: the Edinburgh Postnatal Depression Scale (EPDS), the Patient Health Questionnaire (PHQ-9), the Kessler Psychological Distress scale (K10) and a shortened 6-item version (K6), the Whooley questions and the two-item Generalised Anxiety Disorder scale (GAD-2). Following this, a registered mental health counsellor administered the MINI Plus, a structured clinical diagnostic interview

2018 PLoS ONE

6. Primary care Screening Questionnaire for Depression: reliability and validity of a new four-item tool Full Text available with Trip Pro

Primary care Screening Questionnaire for Depression: reliability and validity of a new four-item tool Unidentified depression in primary care is a public health concern, globally. There is a need for brief, valid and easily administered tools in primary care.To estimate reliability and validity of the newly developed Primary care Screening Questionnaire for Depression (PSQ4D), a four-item tool, with 'yes' or 'no' options.PSQ4D was administered verbally (time required, <1 min) by primary care (...) predictive value was 0.98, positive likelihood ratio was 7.4 and negative likelihood ratio was 0.05.When physician administered, PSQ4D has good reliability. At a cut-off score of ≥2, it has high sensitivity and specificity to identify depressive disorder in primary care.None.© The Royal College of Psychiatrists 2017. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license.

2017 BJPsych open

7. Psychometric properties of the Arabic version of EPDS and BDI-II as a screening tool for antenatal depression: evidence from Qatar. Full Text available with Trip Pro

Psychometric properties of the Arabic version of EPDS and BDI-II as a screening tool for antenatal depression: evidence from Qatar. The current study aimed to validate and determine the psychometric properties of the Arabic versions of the Beck Depression Inventory-II (BDI-II) and the Edinburgh Postnatal Depression Scale (EPDS) in Qatar.A cross-sectional study design was employed.Antenatal care (ANC) clinics at nine primary healthcare centres.Pregnant women (n=128) aged 15-46 years in different (...) trimesters of pregnancy, attending the ANC clinics as well as capable of reading and writing in the Arabic language.A total of 128 participants were enrolled. On conducting the receiver operating characteristic (ROC) analysis, the EPDS showed a larger area under the curve at 0.951 than the BDI-II tool (0.912). Using Youden's index, a score >13 on the EPDS (87% sensitivity, 90% specificity) and >19 on the BDI-II (96% sensitivity, 73% specificity) allowed for the greatest division between depressed and non

2019 BMJ open

8. Getting it Right: validating a culturally specific screening tool for depression (aPHQ-9) in Aboriginal and Torres Strait Islander Australians. Full Text available with Trip Pro

Getting it Right: validating a culturally specific screening tool for depression (aPHQ-9) in Aboriginal and Torres Strait Islander Australians. To determine the validity, sensitivity, specificity and acceptability of the culturally adapted nine-item Patient Health Questionnaire (aPHQ-9) as a screening tool for depression in Aboriginal and Torres Strait Islander people.Prospective observational validation study, 25 March 2015 - 2 November 2016.500 adults (18 years or older) who identified (...) , 71-83%). The aPHQ-9 was deemed acceptable by more than 80% of participants.Indigenous Australians found the aPHQ-9 acceptable as a screening tool for depression. Applying a cut-point of 10 points, the performance characteristics of the aPHQ were good.© 2019 AMPCo Pty Ltd.

2019 Medical Journal of Australia

9. Validation of the Edinburgh postnatal depression scale as a screening tool for depression in Spanish pregnant women. (Abstract)

Validation of the Edinburgh postnatal depression scale as a screening tool for depression in Spanish pregnant women. The Edinburgh Postnatal Depression Scale (EPDS) is a self-reported scale designed to detect postnatal depression, and also has been validated in multiple countries for its use during pregnancy, but not in Spain. The objective of this study was to validate the EPDS as a screening instrument to detect depression during different trimesters of pregnancy in Spanish women.Longitudinal (...) study of a large, unselected sample of 569 pregnant women who were assessed in the first, second and third trimesters of pregnancy by using the EPDS and the Structured Clinical Interview for DSM-IV (SCID). We evaluated the area under the ROC curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy (OA).The optimal cut-off point score of the EPDS for screening current SCID diagnosis of combined depression was 9 or more in the first

2018 Journal of Affective Disorders

10. Study protocol on criterion validation of Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire (PHQ-9) and Centre for Epidemiological Studies-Depression (CES-D) screening tools among rural postnatal women; a cross-sectional study. Full Text available with Trip Pro

Study protocol on criterion validation of Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire (PHQ-9) and Centre for Epidemiological Studies-Depression (CES-D) screening tools among rural postnatal women; a cross-sectional study. Screening women for postnatal depression (PND) provides an opportunity to reach undetected cases and enhance pregnancy outcomes. In Zimbabwe, no validation of depression screening tools has been done on postnatal women in rural settings.This study (...) with PND will enable healthcare providers to link them with care, which will ultimately improve maternal and child health outcomes. Furthermore, this study will provide evidence on which screening tool would be best for screening PND in rural settings of Zimbabwe.© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

2018 BMJ open

11. Screening for Perinatal Depression

Screening for Perinatal Depression INTERIM UPDATE ACOGCOMMITTEEOPINION Number 757 (Replaces Committee Opinion No. 630, May 2015) Committee on Obstetric Practice This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. INTERIM UPDATE: This Committee Opinion is updated as highlighted to reflect a limited, focused change in the language and supporting evidence regarding prevalence, benefits of screening, and screening tools (...) have been validated for use during pregnancy and the postpartum period. The American College of Obstetricians and Gynecologists recommends that obstetrician– gynecologists and other obstetric care providers screen patients at least once during the perinatal period for depression and anxiety symptoms using a standardized, validated tool. It is recommended that all obstetrician– gynecologists and other obstetric care providers complete a full assessment of mood and emotional well-being

2018 American College of Obstetricians and Gynecologists

12. The psychometric properties of depression screening tools in primary healthcare settings: A systematic review. (Abstract)

The psychometric properties of depression screening tools in primary healthcare settings: A systematic review. Consensus on a tool for depression screening among adults in primary healthcare (PHC) settings is lacking. This systematic review aimed to explore the psychometric properties of depression screening tools.A systematic literature search composed of four terms (screening AND psychometric AND depression AND primary healthcare) was conducted in PubMed, EMBASE, PsycINFO and MEDLINE, between (...) January 1995 through October 2015. Studies that aimed to psychometrically test a depression screening tool among the general adult population in a PHC setting were included. Studies exploring the diagnostic properties of depression screening tools among specific populations were excluded.Sixty publications, evaluating the psychometric properties of 55 tools or adaptations, were included. Studies were conducted in 24 countries and 18 languages on 48234 adults. The Patient Health Questionnaire-9

2018 Journal of Affective Disorders

13. Combine these screening tools to detect bipolar depression. (Abstract)

Combine these screening tools to detect bipolar depression. Used together, brief assessment tools, such as the PHQ9 and MDQ, have greater sensitivity and accuracy than clinician assessment alone.

2018 Journal of Family Practice

14. An Examination of Screening Tools for Collaborative Care of Adolescent Depression. (Abstract)

An Examination of Screening Tools for Collaborative Care of Adolescent Depression. Collaborative care models for treatment of adolescent depression are rapidly evolving. However, a dearth of information exists regarding patient characteristics associated with positive outcomes. We explored the association between baseline scores on routine screening tools for substance abuse, mood disorders, and anxiety with depression remission and graduation from a collaborative care program in an outpatient (...) at remission and graduation.Of the 182 patients included in the analysis, the overall remission rate was 55%; program graduation rate was 27%. There was no association between scores on baseline screening tools and remission. Graduation was associated with lower scores on a screening tool for substance abuse (unit odds ratio [OR] = 1.62; P = .01) and anxiety (unit OR = 1.03; P = .02). When the scores were examined as categorical variables, graduation was associated with negative assessments on screening

2018 Journal of Clinical Psychiatry

15. Orthostatic hypotension in patients with late-life depression: Prevalence and validation of a new screening tool. (Abstract)

Orthostatic hypotension in patients with late-life depression: Prevalence and validation of a new screening tool. The objective of this study was to assess the prevalence of orthostatic hypotension (OH) in a sample of late life depression (LLD) patients and to determine the validity of a standardized questionnaire, the Orthostatic Hypotension Questionnaire (OHQ). Secondarily, we wished to assess variables associated with OH.We conducted a cross-sectional study on 82 consecutive geriatric (...) relationship were less likely to have OH. Although the OHQ is a quick to administer paper-based screening test, it did not show adequate diagnostic accuracy in patients with LLD seen in a routine psychiatry clinic.© 2018 John Wiley & Sons, Ltd.

2018 International Journal of Geriatric Psychiatry

16. Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers Full Text available with Trip Pro

Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers There is a need for a brief, reliable, valid, and sensitive assessment tool for screening cognitive deficits in patients with Major Depressive Disorders. This paper examines the psychometric characteristics of THINC-it, a cognitive assessment tool composed of four objective measures of cognition and a self-rated assessment, in subjects (...) without mental disorders.N = 100 healthy controls with no current or past history of depression were tested on four sequential assessments to examine temporal stability, reliability, and convergent validity of the THINC-it tests. We examined temporal reliability across 1 week and stability via three consecutive assessments. Consistency of assessment by the study rater (intrarater reliability) was calculated using the data from the second and third of these consecutive assessments.Test-retest

2018 International journal of methods in psychiatric research

17. Course of depression symptoms between 3 and 8 months after delivery using two screening tools (EPDS and HSCL-10) on a sample of Sudanese women in Khartoum state. Full Text available with Trip Pro

Course of depression symptoms between 3 and 8 months after delivery using two screening tools (EPDS and HSCL-10) on a sample of Sudanese women in Khartoum state. Effects of depression on parenting and on cognitive development of newborns are augmented when symptoms continue throughout the first postnatal year. Current classification systems recognize maternal depression as postnatal if symptoms commence within four to six weeks. Traditional cultural rituals in Sudan offer new mothers adequate (...) family support in the first 6-8 weeks postpartum. The course of postnatal depression symptoms beyond that period is not explored in such settings. We therefore aim to investigate the change in screening status and in severity of depression and distress symptoms between three and eight months postpartum among a sample of Sudanese women using the Edinburgh Postnatal Depression Scale (EPDS) and a locally used tool: the 10-items Hopkins Symptoms Checklist (HSCL-10).Three hundred pregnant women

2018 BMC Pregnancy and Childbirth

18. Combine these screening tools to detect bipolar depression. (Abstract)

Combine these screening tools to detect bipolar depression. Used together, brief assessment tools, such as the PDQ9 and MDQ, have greater sensitivity and accuracy than clinician assessment alone.

2018 Journal of Family Practice

19. The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03686605 Recruitment Status : Enrolling by invitation First Posted : September 27, 2018 Last

2018 Clinical Trials

20. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Full Text available with Trip Pro

Depression screening tools in persons with epilepsy: A systematic review of validated tools. Depression affects approximately 25% of epilepsy patients. However, the optimal tool to screen for depression in epilepsy has not been definitively established. The purpose of this study was to systematically review the literature on the validity of depression-screening tools in epilepsy.MEDLINE, EMBASE, and PsycINFO were searched until April 4, 2016 with no restriction on dates. Abstract, full-text (...) review and data abstraction were conducted in duplicate. We included studies that evaluated the validity of depression-screening tools and reported measures of diagnostic accuracy (e.g., sensitivity, specificity, and negative and positive predictive values) in epilepsy. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies Version 2. Medians and ranges for estimates of diagnostic accuracy were calculated when appropriate.A total of 16,070 abstracts were screened

2017 Epilepsia

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>